Challenges and perspectives on less invasive surgery for early-stage cervical cancer: a critical analysis of the SHAPE trial and its implications.
作者信息
Takekuma Munetaka
机构信息
Department of Gynecology, Shizuoka Cancer Center, Shizuoka, Japan.
出版信息
J Gynecol Oncol. 2024 Mar;35(2):e48. doi: 10.3802/jgo.2024.35.e48.
Abstract
摘要
相似文献
1
Challenges and perspectives on less invasive surgery for early-stage cervical cancer: a critical analysis of the SHAPE trial and its implications.早期宫颈癌微创手术的挑战与前景：对SHAPE试验的批判性分析及其启示
J Gynecol Oncol. 2024 Mar;35(2):e48. doi: 10.3802/jgo.2024.35.e48.
2
Minimally invasive radical hysterectomy and the importance of avoiding cancer cell spillage for early-stage cervical cancer: a narrative review.微创根治性子宫切除术与避免早期宫颈癌癌细胞播散的重要性：一篇叙述性综述。
J Gynecol Oncol. 2023 Jan;34(1):e5. doi: 10.3802/jgo.2023.34.e5. Epub 2022 Nov 10.
3
ROCC/GOG-3043: a randomized controlled trial of robotic versus open surgery for early-stage cervical cancer.ROCC/GOG - 3043：早期宫颈癌机器人手术与开放手术的随机对照试验
Int J Gynecol Cancer. 2025 Feb 28:101760. doi: 10.1016/j.ijgc.2025.101760.
4
Quality of life in patients with cervical cancer after open versus minimally invasive radical hysterectomy (LACC): a secondary outcome of a multicentre, randomised, open-label, phase 3, non-inferiority trial.接受开腹与微创根治性子宫切除术（LACC）的宫颈癌患者的生活质量：一项多中心、随机、开放标签、3 期、非劣效性试验的次要结局。
Lancet Oncol. 2020 Jun;21(6):851-860. doi: 10.1016/S1470-2045(20)30081-4.
5
A Predictive Model for Parametrial Invasion in Patients With FIGO Stage IB Cervical Cancer: Individualized Approach for Primary Treatment.FIGO IB期宫颈癌患者宫旁浸润的预测模型：个体化的初始治疗方法
Int J Gynecol Cancer. 2016 Jan;26(1):184-91. doi: 10.1097/IGC.0000000000000560.
6
Transvaginal cervical tumor-concealing no-look no-touch technique in minimally invasive radical hysterectomy for early-stage cervical cancer: a novel operation technique.经阴道宫颈癌隐匿式免视免触技术在早期宫颈癌微创根治性子宫切除术中的应用：一种新的手术技术。
J Gynecol Oncol. 2023 May;34(3):e27. doi: 10.3802/jgo.2023.34.e27. Epub 2022 Dec 19.
7
Minimally invasive surgical management of early-stage cervical cancer: an analysis of the risk factors of surgical complications and of oncologic outcomes.早期宫颈癌的微创外科治疗：手术并发症风险因素及肿瘤学结局分析
Int J Gynecol Cancer. 2015 May;25(4):714-21. doi: 10.1097/IGC.0000000000000390.
8
The 5-year overall survival of cervical cancer in stage IIIC-r was little different to stage I and II: a retrospective analysis from a single center.宫颈癌 IIIC-r 期 5 年总生存率与 I 期和 II 期无明显差异：单中心回顾性分析。
BMC Cancer. 2021 Feb 27;21(1):203. doi: 10.1186/s12885-021-07890-w.
9
Nerve-sparing radical abdominal trachelectomy versus nerve-sparing radical hysterectomy in early-stage (FIGO IA2-IB) cervical cancer: a comparative study on feasibility and outcome.神经保留式根治性腹式子宫颈切除术与神经保留式根治性子宫切除术治疗早期（FIGOIA2-IB）宫颈癌的比较：可行性和结局的比较研究。
Int J Gynecol Cancer. 2014 May;24(4):735-43. doi: 10.1097/IGC.0000000000000114.
10
Survival after minimally invasive radical hysterectomy with protective colpotomy for early-stage cervical cancer: A systematic review and meta-analysis.早期宫颈癌行微创根治性子宫切除术并保留阴道的生存情况：一项系统评价和荟萃分析。
Eur J Surg Oncol. 2024 Apr;50(4):108240. doi: 10.1016/j.ejso.2024.108240. Epub 2024 Mar 2.
引用本文的文献
1
Gynecologic oncology in 2024: breakthrough trials and evolving treatment strategies for cervical, uterine corpus, and ovarian cancers.2024年妇科肿瘤学：宫颈癌、子宫内膜癌和卵巢癌的突破性试验及不断发展的治疗策略
J Gynecol Oncol. 2025 Jan;36(1):e72. doi: 10.3802/jgo.2025.36.e72.
2
Successful Outcome of Stage IB3 Cervical Cancer Treated With Neoadjuvant Chemotherapy Followed by Vaginal Radical Trachelectomy: A Case Report.新辅助化疗后行阴道根治性宫颈切除术治疗IB3期宫颈癌的成功病例报告
Cureus. 2024 Oct 16;16(10):e71626. doi: 10.7759/cureus.71626. eCollection 2024 Oct.
3
Risks of Cervical Cancer Recurrence After Fertility-Sparing Surgery and the Role of Human Papillomavirus Infection Types.保留生育功能手术后宫颈癌复发的风险及人乳头瘤病毒感染类型的作用
J Clin Med. 2024 Oct 22;13(21):6318. doi: 10.3390/jcm13216318.
4
The SHAPE trial: is good is good enough?SHAPE试验：好就足够了吗？
J Gynecol Oncol. 2024 Jul;35(4):e107. doi: 10.3802/jgo.2024.35.e107. Epub 2024 May 13.
本文引用的文献
1
Simple versus Radical Hysterectomy in Women with Low-Risk Cervical Cancer.低危型宫颈癌患者行简化根治性子宫切除术与根治性子宫切除术的比较。
N Engl J Med. 2024 Feb 29;390(9):819-829. doi: 10.1056/NEJMoa2308900.
2
ESGO/ESTRO/ESP Guidelines for the management of patients with cervical cancer - Update 2023.ESGO/ESTRO/ESP 宫颈癌管理指南-2023 年更新版。
Int J Gynecol Cancer. 2023 May 1;33(5):649-666. doi: 10.1136/ijgc-2023-004429.
3
The IARC Perspective on Cervical Cancer Screening.国际癌症研究机构对宫颈癌筛查的观点。
N Engl J Med. 2021 Nov 11;385(20):1908-1918. doi: 10.1056/NEJMsr2030640.
4
Evidence-Based Treatment Paradigms for Management of Invasive Cervical Carcinoma.浸润性宫颈癌管理的循证治疗模式
J Clin Oncol. 2019 Sep 20;37(27):2472-2489. doi: 10.1200/JCO.18.02303. Epub 2019 Aug 12.
5
Minimally Invasive versus Abdominal Radical Hysterectomy for Cervical Cancer.微创与经腹根治性子宫切除术治疗宫颈癌的比较。
N Engl J Med. 2018 Nov 15;379(20):1895-1904. doi: 10.1056/NEJMoa1806395. Epub 2018 Oct 31.
6
Non-randomized confirmatory trial of modified radical hysterectomy for patients with tumor diameter 2 cm or less FIGO Stage IB1 uterine cervical cancer: Japan Clinical Oncology Group Study (JCOG1101).肿瘤直径2厘米及以下的国际妇产科联盟（FIGO）IB1期子宫颈癌患者改良根治性子宫切除术的非随机验证性试验：日本临床肿瘤学会研究（JCOG1101）
Jpn J Clin Oncol. 2015 Jan;45(1):123-6. doi: 10.1093/jjco/hyu168. Epub 2014 Nov 2.
7
Class II radical hysterectomy in low-risk IB squamous cell carcinoma of cervix: a safe and effective option.II 型根治性子宫切除术治疗低风险宫颈 IB 期鳞状细胞癌：一种安全有效的选择。
Int J Gynecol Cancer. 2009 Jan;19(1):46-9. doi: 10.1111/IGC.0b013e318197f847.
8
Classification of radical hysterectomy.根治性子宫切除术的分类
Lancet Oncol. 2008 Mar;9(3):297-303. doi: 10.1016/S1470-2045(08)70074-3.
9
Modified radical hysterectomy for early Ib cervical cancer.早期Ib期宫颈癌的改良根治性子宫切除术。
Gynecol Oncol. 1999 Aug;74(2):241-4. doi: 10.1006/gyno.1999.5434.
10
Modified radical hysterectomy in the treatment of early squamous cervical cancer.改良根治性子宫切除术治疗早期宫颈鳞状细胞癌。
Gynecol Oncol. 1999 Feb;72(2):183-6. doi: 10.1006/gyno.1998.5245.
Zotero 插件